Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma

BACKGROUND: There is little evidence of combining sorafenib with hepatic arterial infusion chemotherapy (HAIC) after transarterial chemoembolization (TACE) for intermediate and advanced hepatocellular carcinoma (HCC). It is important to identify that patients with intermediate and advanced HCC are m...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bao-Jiang, Gao, Song, Zhu, Xu, Guo, Jian-Hai, Zhang, Xin, Chen, Hui, Wang, Xiao-Dong, Yang, Ren-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341000/
https://www.ncbi.nlm.nih.gov/pubmed/32699581
http://dx.doi.org/10.4251/wjgo.v12.i6.663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341000/
https://www.ncbi.nlm.nih.gov/pubmed/32699581
http://dx.doi.org/10.4251/wjgo.v12.i6.663

Ejemplares similares